Sorrel to Open a New Manufacturing Facility
The new site will offer initial design and development, low-volume manufacturing, and scalable high-quality production of wearable drug delivery devices.
Sorrel Medical, an Israel-based developer and manufacturer of wearable drug delivery devices, announced on July 7, 2020 that it is opening a new manufacturing facility with cleanroom facilities to further scale its wearable drug delivery devices.
According to a company press release, the new site will offer initial design and development, low-volume manufacturing, and scalable high-quality production of wearable drug delivery devices. With the new 80-m2 cleanroom, the company will be able to increase its production capacity to hundreds of thousands of units per year.
“As Sorrel continues to grow, this new facility will enable us to support global pharmaceutical and biotechnology partners to bring next-generation drug delivery solutions to patients," said Bentsi Algazi, vice president of Operations at Sorrel, in the press release. "These enhanced production scale-up capabilities will enable us to positively impact countless patients living with chronic and high burden conditions."
Source: Sorrel
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
